NG
AMGN icon

NatWest Group’s Amgen AMGN Stock Holding History

NatWest Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Sell
31,140
-4,657
-13% -$1.59M 2.01% 21
2026
Q1 		$12.6M Buy
+35,797
New +$12.8M 2.72% 11
2024
Q1 		– Sell
-18,986
Closed -$5.47M – 36
2023
Q4 		$5.47M Buy
18,986
+10,476
+123% +$2.85M 2.29% 19
2023
Q3 		$2.29M Sell
8,510
-57
-0.7% -$14.2K 1.19% 26
2023
Q2 		$1.9M Sell
8,567
-141
-2% -$32.7K 0.99% 29
2023
Q1 		$2.11M Sell
8,708
-7,043
-45% -$1.73M 1.14% 27
2022
Q4 		$4.14M Sell
15,751
-205
-1% -$55K 2.35% 19
2022
Q3 		$3.6M Sell
15,956
-2,534
-14% -$614K 2.09% 20
2022
Q2 		$4.5M Buy
18,490
+1,648
+10% +$404K 2.55% 19
2022
Q1 		$4.07M Buy
16,842
+3,733
+28% +$858K 1.96% 24
2021
Q4 		$2.95M Buy
13,109
+2,478
+23% +$523K 1.52% 26
2021
Q3 		$2.26M Buy
10,631
+4,896
+85% +$1.13M 1.21% 29
2021
Q2 		$1.4M Buy
5,735
+49
+0.9% +$12.1K 0.72% 34
2021
Q1 		$1.42M Buy
5,686
+82
+1% +$19.6K 0.68% 35
2020
Q4 		$1.29M Sell
5,604
-688
-11% -$159K 0.47% 45
2020
Q3 		$1.6M Buy
+6,292
New +$1.56M 0.34% 44
2015
Q4 		– Sell
-85,316
Closed -$11.8M – 141
2015
Q3 		$11.8M Buy
85,316
+3,912
+5% +$617K 0.26% 43
2015
Q2 		$12.5M Sell
81,404
-7,840
-9% -$1.26M 0.16% 42
2015
Q1 		$14.3M Buy
89,244
+940
+1% +$148K 0.19% 35
2014
Q4 		$14.1M Buy
88,304
+1,603
+2% +$250K 0.12% 35
2014
Q3 		$12.2M Sell
86,701
-12,870
-13% -$1.68M 0.1% 54
2014
Q2 		$11.8M Buy
99,571
+391
+0.4% +$45.3K 0.5% 56
2014
Q1 		$12.2M Sell
99,180
-59,767
-38% -$7.25M 0.54% 52
2013
Q4 		$18.1M Buy
158,947
+12,104
+8% +$1.38M 0.46% 50
2013
Q3 		$16.4M Sell
146,843
-166,816
-53% -$18.1M 0.48% 50
2013
Q2 		$30.9M Buy
+313,659
New +$32.5M 0.44% 43

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

NatWest Group's AMGN Position: Q2 2026 in Review

NatWest Group reduced its Amgen (AMGN) stake by 13% in Q2 2026, selling an estimated $1.59M and leaving 31,140 shares worth $11.3M. The position accounts for 2.01% of the portfolio, ranked #21.

NatWest Group first reported a position in AMGN in Q2 2013 and has held it in 26 quarters since. The position peaked at $30.9M in Q2 2013. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • NatWest Group held 31,140 shares of Amgen worth $11.3M as of Q2 2026.
  • NatWest Group sold 4,657 Amgen shares in Q2 2026, an estimated $1.59M.
  • Amgen made up 2.01% of NatWest Group's portfolio in Q2 2026, its #21 holding.
  • NatWest Group first reported a position in Amgen in Q2 2013 and has held it in 26 quarters since.
  • NatWest Group's Amgen position peaked at $30.9M in Q2 2013.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on NatWest Group's 13F filing for Q2 2026, filed 10 Aug 2026.